AbbVie Reports Second-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Broadcom rises 3% on OpenAI custom "Jalapeño" chip reveal
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
AbbVie (ABBV) Tops Q2 EPS by 15c, Issues Combined Company Guidance
July 31, 2020 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q2 EPS of $2.34, $0.15 better than the analyst estimate of $2.19. Revenue for the quarter came in at $10.43 billion versus the consensus estimate of $10.08 billion.
Full-Year 2020 Outlook:
AbbVie previously issued standalone GAAP diluted EPS guidance for the full-year... More
